Mereo BioPharma Group reports Q1 EPS ($0.02) vs FactSet ($0.01) [7 est, ($0.09)-0.07] ($2.50, 0.00)
StreetAccount Summary: Stocks reaching new 52-week highs/lows (697 total)
StreetAccount Summary: Stocks reaching new 52-week highs/lows (1167 total)
StreetAccount Summary: Stocks reaching new 52-week highs/lows (1064 total)
StreetAccount Summary: Stocks reaching new 52-week highs/lows (178 total)
StreetAccount Summary: Stocks reaching new 52-week highs/lows (465 total)
Powered by FactSet Research Systems Inc.